[Ciprofibrate-induced acute cholestatic hepatitis].
作者信息
Pflumio F, Andrès E, Ubrich M, Geisler F, Imbs J-L, Di Liberatore M
机构信息
Service de Médecine, Cliniques Médicale B des Hôpitaux Universitaires de Strasbourg.
出版信息
Ann Endocrinol (Paris). 2003 Jun;64(3):232-3.
PMID:12910067
Abstract
摘要
相似文献
1
[Ciprofibrate-induced acute cholestatic hepatitis].
Ann Endocrinol (Paris). 2003 Jun;64(3):232-3.
2
[Acute severe fibrosing hepatitis associated with ciprofibrate treatment].
Gastroenterol Clin Biol. 1999 Dec;23(12):1399-400.
3
[Cytolytic hepatic damage caused by ciprofibrate].[环丙贝特引起的细胞溶解性肝损伤]
Gastroenterol Clin Biol. 1992;16(6-7):609.
4
[Acute rhabdomyolysis during treatment with ciprofibrate].[环丙贝特治疗期间的急性横纹肌溶解症]
Presse Med. 1990 Nov 24;19(39):1811-2.
5
Ciprofibrate and lipid profile.
Lancet. 1994 Oct 1;344(8927):955. doi: 10.1016/s0140-6736(94)92307-8.
6
Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment.在同时使用环丙贝特和布洛芬治疗的情况下，因横纹肌溶解症导致的急性肾衰竭。
BMJ. 1997 May 31;314(7094):1593. doi: 10.1136/bmj.314.7094.1593a.
7
[Rhabdomyolysis and unexplained malaise. Role of combination of ciprofibrate and norfloxacin].[横纹肌溶解症与不明原因的不适。环丙贝特与诺氟沙星联合应用的作用]
Rev Med Interne. 1996;17(10):859-60. doi: 10.1016/0248-8663(96)82696-8.
8
Severe rhabdomyolysis during a hypersensitivity reaction to abacavir in a patient treated with ciprofibrate.
AIDS. 2005 Nov 4;19(16):1927-8. doi: 10.1097/01.aids.0000189861.44311.ed.
9
Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
Metabolism. 2001 Nov;50(11):1385-6. doi: 10.1053/s0026-0495(01)90010-1.
10
[Does hypothyroidism predispose muscular toxicity of fibrates?].[甲状腺功能减退症是否易导致贝特类药物的肌肉毒性？]
Rev Med Interne. 1991 Mar-Apr;12(2):159. doi: 10.1016/s0248-8663(05)81387-6.
Zotero 插件